News archive for Centre for Cancer Biomarkers CCBIO

The PhD level course on Health Innovation, CCBIONEUR912, was kicked off November 8-9, 2021, at the facilities of the new medical incubator EITRI. CCBIONEUR912 is joining the course SDG900 as the second innovation course offering at UiB on the PhD level. It is the first PhD course on health innovation and thus an invaluable offering for medical researchers at the beginning of their research... Read more

November 9, Professor Robert S. Langer, Massachusetts Institute of Technology, presented the Falch Lecture entitled "Creating and implementing breakthrough technologies in biotechnology and nanotechnology". Through a live streaming from MIT, the around 200 people in Store Auditorium enjoyed a truly inspirational talk, motivating them to pursue their ideas and keep asking the fundamental questions.

On October 20, CCBIO hosted a Celebration Seminar to celebrate the awarding of the King Olav V’s Prize for Cancer Research 2021 to Professor Bjørn Tore Gjertsen. Leaders from the university and the hospital as well as close colleagues gave highly praising speeches and scientific talks.

Dana Costea is this year’s receiver of the Pindborg Prize, an annual award issued by The Scandinavian Fellowship of Oral Pathology and Oral Medicine (SFOPOM), in memory of the late Professor Jens J. Pindborg, internationally renowned dentist and pathologist.

CCBIO initiated its research school – CCBIO Research School for Cancer Studies (RSCS) – very early on, and the RSCS has since the startup in 2014 undergone a steady progress and expansion of the course portfolio. Now that CCBIO’s parent department the Department of Clinical Medicine has been assigned an FKB center (Centre for Clinical Treatment Research) – Neuro-SysMed – CCBIO is happy to be able... Read more

In collaboration with the Vascular Biology Program (VBP), Boston Children’s Hospital, CCBIO recently completed the second CCBIO INTPART long course CCBIO907. This year, the course was given in digital format, and it was well visited by local students and researchers, participants from other institutions all over Norway, and also from Finland, Sweden and Denmark, in addition to some from other... Read more

The pandemic situation and lockdown of campus has forced CCBIO to think new in order to fulfill the goals for the CCBIO Research School for Cancer Studies. On fairly short notice, the 2 planned spring courses were rescheduled to new dates and organized through digital platforms. Despite of limited time to get the word out, registration for both courses soon had to be closed, due to great interest... Read more

CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”